An artificial pancreas developed by Boston researchers shows considerable promise to dramatically change the treatment of type 1 diabetes, potentially enabling 2 million Americans to eat what they want without counting carbohydrates or calculating insulin injections, researchers announced Sunday. Steven Russell, assistant professor of medicine at Massachusetts General Hospital, led the study. Howard Wolpert, associate professor of medicine at Joslin Diabetes Center, reviewed the paper.
News & Research
